Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma 7Lymphoma, Follicular 6Leukemia, Biphenotypic, Acute 6Leukemia 6Lymphoma, Non-Hodgkin 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Large-Cell, Immunoblastic 3Leukemia, Myeloid, Acute 3Burkitt Lymphoma 3Prostatic Neoplasms 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms 2Multiple Myeloma 2Lymphohistiocytosis, Hemophagocytic 2Leukemia, Lymphocytic, Chronic, B-Cell 2Graft vs Host Disease 2Epstein-Barr Virus Infections 2Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pneumonia, Pneumocystis 1Pneumonia 1Pain 1Neurotoxicity Syndromes 1Neuroma, Acoustic 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Lymphoma, Large-Cell, Anaplastic 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Leukemia, Myeloid, Chronic-Phase 1

Interventions

Leucovorin 22Fluorouracil 22Paclitaxel 21Gemcitabine 21Docetaxel 21Capecitabine 21Irinotecan 16Carboplatin 15Radiosurgery 14Oxaliplatin 13Cisplatin 13Bevacizumab 13Zoledronic Acid 12pembrolizumab 11Radiotherapy 11Fulvestrant 11palbociclib 9Pemetrexed 9Drug Therapy 9130-nm albumin-bound paclitaxel 9Surgical Procedures, Operative 7Letrozole 7Ibandronic Acid 7abemaciclib 6Trastuzumab 6Prednisone 6Vinorelbine 5Folfox protocol 5Floxuridine 5Doxorubicin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Neoplasm Metastasis × Methylprednisolone × Clear all
NCT02887976 2020-07-22

Extension of SoluMatrix TM Abiraterone Acetate in Patients Who Completed Study Number CHL-AA-201

GU Research Network, LLC

Phase 3 Completed
2 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡